ATE423761T1 - Disubstituierte chalcogenoxime mit antagonistischer wirkung am rar(gamma)- retinoidrezeptor - Google Patents
Disubstituierte chalcogenoxime mit antagonistischer wirkung am rar(gamma)- retinoidrezeptorInfo
- Publication number
- ATE423761T1 ATE423761T1 AT04815018T AT04815018T ATE423761T1 AT E423761 T1 ATE423761 T1 AT E423761T1 AT 04815018 T AT04815018 T AT 04815018T AT 04815018 T AT04815018 T AT 04815018T AT E423761 T1 ATE423761 T1 AT E423761T1
- Authority
- AT
- Austria
- Prior art keywords
- rar
- gamma
- chalcogen
- oximes
- disubstituted
- Prior art date
Links
- 102000027483 retinoid hormone receptors Human genes 0.000 title abstract 2
- 108091008679 retinoid hormone receptors Proteins 0.000 title abstract 2
- -1 CHALCOGEN OXIMES Chemical class 0.000 title 1
- 230000003042 antagnostic effect Effects 0.000 title 1
- 229910052798 chalcogen Inorganic materials 0.000 title 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53283503P | 2003-12-26 | 2003-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE423761T1 true ATE423761T1 (de) | 2009-03-15 |
Family
ID=34748824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04815018T ATE423761T1 (de) | 2003-12-26 | 2004-12-21 | Disubstituierte chalcogenoxime mit antagonistischer wirkung am rar(gamma)- retinoidrezeptor |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7253319B2 (https=) |
| EP (1) | EP1701934B1 (https=) |
| JP (1) | JP2007518719A (https=) |
| AT (1) | ATE423761T1 (https=) |
| CA (1) | CA2551294A1 (https=) |
| DE (1) | DE602004019685D1 (https=) |
| MX (1) | MXPA06007255A (https=) |
| WO (1) | WO2005066115A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7476673B2 (en) * | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
| CN101481352A (zh) | 2008-01-10 | 2009-07-15 | 上海恒瑞医药有限公司 | 双环取代吡唑酮偶氮类衍生物、其制备方法及其在医药上的应用 |
| CA2751820A1 (en) * | 2009-02-10 | 2010-08-19 | Nippon Soda Co., Ltd. | Nitrogen-containing compounds and harmful organism control agents |
| CN101921232A (zh) | 2009-06-11 | 2010-12-22 | 上海恒瑞医药有限公司 | 双环取代吡唑酮偶氮类衍生物的盐,其制备方法及其在医药上的应用 |
| MX2012006776A (es) | 2009-12-14 | 2012-10-05 | Merck Patent Gmbh | Inhibidores de la esfingosina quinasa. |
| CA2784647A1 (en) | 2009-12-17 | 2011-07-14 | Merck Patent Gmbh | Inhibitors of sphingosine kinase |
| US20140194517A1 (en) * | 2013-01-08 | 2014-07-10 | Io Therapeutics, Inc. | Treatment of Graft-Versus-Host Disease Disorders using RAR Antagonists |
| CN110090237B (zh) * | 2019-05-30 | 2021-05-28 | 四川农业大学 | 一种用于治疗维生素a中毒所致肝损伤和骨损伤的药物及用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0024982B1 (fr) | 1979-08-22 | 1984-11-28 | Léo Jouk | Vélo à cadre télescopique adaptable en vélo d'appartement |
| FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
| JP4001618B2 (ja) | 1991-12-18 | 2007-10-31 | ザ ソールク インスチチュート フォア バイオロジカル スタディズ | レチノイド受容体によって仲介される過程の修飾方法およびそれに有用な化合物 |
| EP0638071B1 (en) | 1992-12-28 | 1997-04-09 | Eisai Co., Ltd. | Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| US5455265A (en) * | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
| US5599967A (en) * | 1994-12-29 | 1997-02-04 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity |
| US5776699A (en) * | 1995-09-01 | 1998-07-07 | Allergan, Inc. | Method of identifying negative hormone and/or antagonist activities |
| US5958954A (en) * | 1995-09-01 | 1999-09-28 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| US5952345A (en) * | 1995-09-01 | 1999-09-14 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| US5877207A (en) * | 1996-03-11 | 1999-03-02 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| US5723666A (en) * | 1996-06-21 | 1998-03-03 | Allergan | Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| PT101919B (pt) * | 1996-09-30 | 2000-01-31 | Hovione Sociedade Quimica Sa | Um processo para a purificacao de tohexol |
| US5739338A (en) * | 1996-11-05 | 1998-04-14 | Allergan | N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity |
| US5760276A (en) * | 1997-03-06 | 1998-06-02 | Allergan | Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| US6037488A (en) * | 1997-04-19 | 2000-03-14 | Allergan Sales, Inc. | Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| US5919970A (en) * | 1997-04-24 | 1999-07-06 | Allergan Sales, Inc. | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
| US6313168B1 (en) * | 1999-12-15 | 2001-11-06 | Allergan Sales, Inc. | Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| US20030114482A1 (en) * | 1999-12-15 | 2003-06-19 | Maurizio Pacifici | Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies |
| SI1324970T1 (sl) * | 2000-10-02 | 2009-02-28 | Hoffmann La Roche | Retinoidi za zdravljenje emfizema |
| US20020193403A1 (en) * | 2001-05-03 | 2002-12-19 | Allergan Sales, Inc. | Methods of treating hyperlipidemia |
-
2004
- 2004-12-21 JP JP2006547254A patent/JP2007518719A/ja active Pending
- 2004-12-21 WO PCT/US2004/042892 patent/WO2005066115A2/en not_active Ceased
- 2004-12-21 MX MXPA06007255A patent/MXPA06007255A/es active IP Right Grant
- 2004-12-21 CA CA002551294A patent/CA2551294A1/en not_active Abandoned
- 2004-12-21 AT AT04815018T patent/ATE423761T1/de not_active IP Right Cessation
- 2004-12-21 DE DE602004019685T patent/DE602004019685D1/de not_active Expired - Lifetime
- 2004-12-21 EP EP04815018A patent/EP1701934B1/en not_active Expired - Lifetime
- 2004-12-23 US US11/021,471 patent/US7253319B2/en not_active Expired - Fee Related
-
2007
- 2007-06-04 US US11/810,047 patent/US7432388B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005066115A2 (en) | 2005-07-21 |
| EP1701934B1 (en) | 2009-02-25 |
| CA2551294A1 (en) | 2005-07-21 |
| WO2005066115A8 (en) | 2005-10-27 |
| DE602004019685D1 (de) | 2009-04-09 |
| MXPA06007255A (es) | 2006-08-18 |
| US7253319B2 (en) | 2007-08-07 |
| EP1701934A2 (en) | 2006-09-20 |
| JP2007518719A (ja) | 2007-07-12 |
| US7432388B2 (en) | 2008-10-07 |
| WO2005066115A3 (en) | 2006-01-12 |
| US20080097119A1 (en) | 2008-04-24 |
| US20050165095A1 (en) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2009004I1 (el) | Υποκατεστημενες με φθοριο κυκλοαλκανοϊνδολες και η χρηση τους ως ανταγωνιστες των υποδοχεων προσταγλανδινης d2 | |
| DE60314347D1 (de) | Betriebsmittelverwaltungsgerät | |
| DE602004025349D1 (de) | Halbleiterbauelement mit bandlücken-angepasstem üb | |
| CY1108378T1 (el) | 4-υποκατεστημενα παραγωγα 1-αμινοκυκλοεξανιου για την χρησιμοποιηση σαν προσδεματα υποδοχεα orl1 ή οπιακου υποδοχεα mu | |
| EP1471972A4 (en) | MICROELECTRONIC STIMULATOR ARRAY | |
| ATE404537T1 (de) | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung | |
| NI201100118A (es) | N-oxipiperidinas espiroheterociclicas como pesticidas. | |
| FI20030662L (fi) | Laitteenhallinta | |
| ITRM20030188A0 (it) | Attrezzatura per il collaudo automatico di dispositivi a semiconduttori. | |
| AU2003253441A1 (en) | Spiro compound and organic luminescence device using the same | |
| EP1794256A4 (en) | NEW CONNECTION AND THIS USING ORGANIC LIGHT-EMITTING DEVICE (2) | |
| MXPA05001354A (es) | Piperidina-ftalazonas sustituidas por pirrolidinodiona como inhibidores pde4. | |
| ECSP045255A (es) | Cumarinas utiles como biomarcadores | |
| DK1499316T3 (da) | (1-4-piperidinyl)benzimidazolderivater anvendelige som histamin-H3-antagonister | |
| ITTO20020723A0 (it) | Struttura di manto erboso sintetico | |
| CY1107156T1 (el) | Νεα μεθοδος συνθεσης του (7-μεθοξυ-3,4-διυδρο-1-ναφθαλινυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης | |
| ATE423761T1 (de) | Disubstituierte chalcogenoxime mit antagonistischer wirkung am rar(gamma)- retinoidrezeptor | |
| ITTO20031020A1 (it) | Apparecchiatura di volatilizzazione. | |
| EP1471387A3 (en) | Photosensitive composition and compound used thereof | |
| DK1636221T3 (da) | 3-Heterocyclyl-azetidin-forbindelser, som er nytte som NK1/NK2 receptorantagonister | |
| DE602004026022D1 (de) | Sulfoniumsalze als Photoinitiatoren | |
| NO20044373L (no) | Azetidinderivater som CCR-3-reseptorantagonister | |
| EP3530658A3 (en) | Heterocyclic compound and organic light-emitting device including the same | |
| DE60328272D1 (de) | Diazabicycloalkan-derivate mit nk1-antagonistischer wirkung | |
| DE602004005801D1 (de) | Bandbreitenmanagement gestützt auf statistische Messungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |